Elenco delle più significative pubblicazioni su riviste internazionali degli ultimi anni cui ha partecipato come autore

ANTONIO BELLOBUONO, S.TEMPINI, D.GRIMOLDI, C.CATTANEO, ANDREA BELLOBUONO, G.IDÉO
Efficacy and tolerability of consensus IFN and ribavirin combination therapy in naive patients affected by chronic hepatitis C with genotype 1 and high viral load.
Hepatology 2001, 34, 337A.

ANTONIO BELLOBUONO, S.TEMPINI, D.GRIMOLDI, L.MONDAZZI, G.M.IDÉO, C.CATTANEO, ANDREA BELLOBUONO, G.IDÉO
IFN alfa-con1 + Ribavirin combination therapy in naive difficult-to-treat patients affected by chronic hepatitis C
J.Hepatol. , 2001, 34, 1, 481A.

ANTONIO BELLOBUONO, S.TEMPINI, C.CATTANEO, D.GRIMOLDI, ANDREA BELLOBUONO, F.DI BERARDINO, G.M. IDÉO, G.IDÉO
Comparison between IFN induction therapy, IFN induction + Ribavirin and IFN + Ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1 : Final report
J.Hepatol. , 2001, 34, 482A.

F.MAROTTA, A.ROUGE, M.HARADA, H.ANZULOVIC, G.M.IDÉO, N.YANAIHARA, G.PRINCESS, G.IDÉO
Beneficial Effect of a Controlled Chinese Herbal Remedy, K-17.22, in CCl4-Induced liver Toxicity: an in vivo and in vitro Study
Biomedical Research 2001, 22, 167-173.

S.BRUNO, P.M.BATTEZZATI, G.BELLATI, A.MANZIN, M.MAGGIONI, A.CROSIGNANI, M.BORZIO, L.SOLFOROSI, A.MORABITO, G.IDÉO, M.PODDA
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.
J.Hepatol. 2001, 34, 748-55.

F. MAROTTA, P. SAFRAN, H. TAJIRI, G. PRINCESS, H. ANZULOVIC, G.M. IDÉO, A. ROUGE, M.G. SEAL, G.IDÉO
Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
Hepatogastroenterology. 2001 , 48, 511-7.

ANTONIO BELLOBUONO, S.TEMPINI, L.MONDAZZI, G.M.IDÉO, P.BRASCA, ANDREA BELLOBUONO, G.IDÉO
Comparison between IFN induction therapy, IFN induction + Ribavirin and IFN + Ribavirin standard combination herapy in naive patients with chronic hpatitis C related to genotype 1.
Hepatology, 2000, 32, 367A.

L.S.BELLI, A.B.ALBERTI, A.AIROLDI, A.CERNUSCHI, G.RONDINARA,L.DE CARLIS, D.FORTI, A.DE GASPERI, A.CORTI, E.MAZZA, G.IDÉO, G.PINZELLO
Early ribavirin treatment and avoidance of steroids in HCV positive liver transplant candidates: preliminary report of a prospective randomized trial.
J.Hepatol. 2000, 32, 44.

N.TASSOPOULOS, S.HADZIYANNIS, G.IDÉO, R.JUREWICZ, C.YOUNG, R.SALTZMAN, C.TREPO, F.BONINO for the Famciclovir Anti-Hbe+ Chronic Hepatitis B Study Group
Famciclovir treatment of anti-HBE+ chronic hepatitis B : results of a randomized, placebo-controlled study
J.Hepatol. 2000, 32, 102.

A.BELLOBUONO, S.TEMPINI, G.M.IDÉO, D.GRIMOLDI, P.BRASCA, G.IDÉO
Comparison between IFN induction, induction+ribavirin and IFN+ribavirin combination therapy in naive èpatients with chronic hepatitis C related to genotype 1.
J.Hepatol. 2000, 32, 110.

A.BELLOBUONO, S.TEMPINI, G.M.IDÉO, P.BRASCA, L.MONDAZZI, G.ANTONELLI, G.IDÉO
AlfaIFN and ribavirin combination therapy reduces the occurrence of breakthrough in chronic hepatitis C.
J.Hepatol. 2000, 32, 111.

A.BELLOBUONO, S.TEMPINI, G.M.IDÉO, D.GRIMOLDI, L.MONDAZZI, P.BRASCA, G.IDÉO
Effect of 12 month alfaIFN and ribavirin combination therapy in chronic hepatitis C unresponsive to alfaIFN.
J.Hepatol. 2000, 32, 178.

BELLOBUONO A. , MONDAZZI L. , TEMPINI S., CHIODO F., MAGLIANO E., FURIONE L., IDÉO G.
“Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy”
Journal Hepatol, 2000 Sept. 33(3) , 463-468

BELLI LS, ZAVAGLIA C, ALBERTI AB, POLI F, RONDINARA G, SILINI E, TAIOLI E, DE CARLIS L, SCALAMOGNA M, FORTI D, PINZELLO G, IDÉO G.
“Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.”
Hepatology. 2000 Jun;31(6):1345-50.

ZAVAGLIA C, SEVERINI R, TINELLI C, FRANZONE JS, AIROLDI A, TEMPINI S, BETTALE G, IDÉO G.
“A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.”
Dig Dis Sci. 2000 Apr;45(4):690-6.

COLLOREDO G, BELLATI G, SONZOGNI A, ZAVAGLIA C, FRACASSETTI O, LEANDRO G, GHISLANDI R, MINOLA E, IDÉO G.
“Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B.”
J Viral Hepat. 1999 Nov;6(6):429-34.

COLLOREDO G, ROFFI L, BRUNETTO MR, LEANDRO G, BRUGNETTI B, BISSOLI F, SCALORI A, MANCIA G, CIVARDI E, IDÉO G, BONINO F, BELLATI G.
“Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy.”
J Viral Hepat. 1999 Sep;6(5):373-80.

IDÉO G, BELLOBUONO A, TEMPINI S, MONDAZZI L, AIROLDI A, BENETTI G, BISSOLI F, CESTARI C, COLOMBO E, DEL POGGIO P, FRACASSETTI O, LAZZARONI S, MARELLI A, PARIS B, PRADA A, RAINER E, ROFFI L.
“Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study”
Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1203-7.

MAROTTA F, TAJIRI H, SAFRAN P, FESCE E, IDÉO G.
“Ethanol-related gastric mucosal damage: evidence of a free radical-mediated mechanism and beneficial effect of oral supplementation with bionormalizer, a novel natural antioxidant.”
Digestion. 1999 Nov-Dec;60(6):538-43.

BAUDO F, CAIMI TM, REDAELLI R, DE CATALDO F, SOMAINI G, RONDINARA GF, DEGASPERI A, BELLATI G, BELLI LS, IDÉO G, MORFINI M, LONGO G.
“Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis.
Haemophilia. 1999 Jul;5(4):276-277.

OLIVERI F, SANTANTONIO T, BELLATI G, COLOMBATTO P, MELS GC, CARRIERO L, DASTOLI G, PASTORE G, IDÉO G, BONINO F, BRUNETTO MR.
“Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.”
Am J Gastroenterol. 1999 May;94(5):1366-72.

ASTI M, MARTINETTI M, ZAVAGLIA C, CUCCIA MC, GUSBERTI L, TINELLI C, CIVIDINI A, BRUNO S, SALVANESCHI L, IDÉO G, MONDELLI MU, SILINI EM.
“Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease.”
Hepatology. 1999 Apr;29(4):1272-9.

BELLI LS, ZAVAGLIA C, ALBERTI AB, RONDINARA GF, DE CARLIS L, SILINI E, POLI F, SCALAMOGNA M, TINELLI C, FORTI D, IDÉO G.
“Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation.”
Transplant Proc. 1999 Feb-Mar;31(1-2):483-4.

BELLOBUONO A, MONDAZZI L, TEMPINI S, CHIODO F, MAGLIANO E, MONDINI C, IDÉO G.
“Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?”
J Hepatol. 1999 Jan;30(1):8-13.

ANDREONE P, CARACENI P, GRAZI GL, BELLI L, MILANDRI GL, ERCOLANI G, JOVINE E, D'ERRICO A, DAL MONTE PR, IDÉO G, FORTI D, MAZZIOTTI A, CAVALLARI A, BERNARDI M.
“Lamivudine treatment for acute hepatitis B after liver transplantation.”
J Hepatol. 1998 Dec;29(6):985-9.

CROSIGNANI A, BUDILLON G, CIMINO L, DEL VECCHIO BLANCO C, LOGUERCIO C, IDÉO G, RAIMONDO G, STABILINI R, PODDA M. 
“Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.”
Hepatogastroenterology. 1998 Sep-Oct;45(23):1624-9.

SILINI E, BELLI L, ALBERTI AB, ASTI M, CERINO A, BISSOLATI M, RONDINARA G, DE CARLIS L, FORTI D, MONDELLI MU, IDÉO G.
“HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.”
J Hepatol. 1998 Oct;29(4):533-40.

POYNARD T, MARCELLIN P, LEE SS, NIEDERAU C, MINUK GS, IDÉO G, BAIN V, HEATHCOTE J, ZEUZEM S, TREPO C, ALBRECHT J.
“Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group.”
Lancet. 1998 Oct 31;352(9138):1426-32.

FESCE E, AIROLDI A, MONDAZZI L, MAGGI G, GUBERTINI G, BERNASCONI G, DEL POGGIO P, BOZZETTI F, IDÉO G.
“Intramuscular beta interferon for chronic hepatitis C: is it worth trying?”
Ital J Gastroenterol Hepatol. 1998 Apr;30(2):185-8.

COLELLA G, BOTTELLI R, DE CARLIS L, SANSALONE CV, RONDINARA GF, ALBERTI A, BELLI LS, GELOSA F, IAMONI GM, RAMPOLDI A, DE GASPERI A, CORTI A, MAZZA E, ASENI P, MERONI A, SLIM AO, FINZI M, DI BENEDETTO F, MANOCHEHRI F, FOLLINI ML, IDÉO G, FORTI D.
“Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization”.
Transpl Int. 1998;11 Suppl 1:S193-6.

BRAMBILLA S, BELLATI G, ASTI M, LISA A, CANDUSSO ME, D'AMICO M, GRASSI G, GIACCA M, FRANCHINI A, BRUNO S, IDÉO G, MONDELLI MU, SILINI EM.
“Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.”
Hepatology. 1998 Jun;27(6):1678-86.

BELLI LS, DE CARLIS L, RONDINARA G, ALBERTI AB, BELLATI G, DE GASPERI A, FORTI D, IDÉO G.
“Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial.”
Hepatology. 1998 Jun;27(6):1524-9.

ZAVAGLIA C, MARTINETTI M, SILINI E, BOTTELLI R, DAIELLI C, ASTI M, AIROLDI A, SALVANESCHI L, MONDELLI MU, IDÉO G.
“Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.”
J Hepatol. 1998 Jan;28(1):1-7.

BELLOBUONO A, MONDAZZI L, TEMPINI S, SILINI E, IDÉO G.
“Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.”
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1169-77.

CASPANI B, CECCONI P, BOTTELLI R, DELLA VIGNA P, IDÉO G, GOZZI G.
“[The interstitial photocoagulation with laser light of liver tumors].”
Radiol Med (Torino). 1997 Oct;94(4):346-54.

MAROTTA F, REIZAKOVIC I, TAJIRI H, SAFRAN P, IDÉO G.
“Abstinence-induced oxidative stress in moderate drinkers is improved by bionormalizer.”
Hepatogastroenterology. 1997 Sep-Oct;44(17):1360-6.

BELLI LS, SILINI E, ALBERTI A, BELLATI G, VAI C, MINOLA E, RONDINARA G, DE CARLIS L, ASTI M, IDÉO G.
“Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation.”
Liver Transpl Surg. 1996 May;2(3):200-5.

ZAVAGLIA C, MONDAZZI L, IAMONI G, AIROLDI A, IDÉO G.
“Immunogenetic factors and disease severity in chronic hepatitis C.”
J Hepatol. 1997 Jul;27(1):248-9.

SCHALM SW, HANSEN BE, CHEMELLO L, BELLOBUONO A, BROUWER JT, WEILAND O, CAVALLETTO L, SCHVARCZ R, IDÉO G, ALBERTI A.
“Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.”
J Hepatol. 1997 May;26(5):961-6.

BELLOBUONO A, MONDAZZI L, TEMPINI S, SILINI E, VICARI F, IDÉO G.
“Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.”
J Viral Hepat. 1997 May;4(3):185-91.

ZAVAGLIA C, MONDAZZI L, MAGGI G, IAMONI G, GELOSA F, BELLATI G, COLLOREDO G, BOTTELLI R, IDÉO G.
“Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?”
Liver. 1997 Apr;17(2):83-7.

ZAVAGLIA C, BELLI LS, ALBERTI AB, IDÉO G, SILINI E.
“Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infection.”
Am J Gastroenterol. 1997 Apr;92(4):725-6.

ALBERTI AB, BELLI LS, SILINI E, ZAVAGLIA C, IAMONI G, RONDINARA GF, DE CARLIS L, FORTI D, IDÉO G.
“Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation.”
Transplant Proc. 1997 Feb-Mar;29(1-2):522-3.

COLELLA G, DE CARLIS L, RONDINARA GF, SANSALONE CV, BELLI LS, ASENI P, SLIM AO, GELOSA F, IAMONI GM, CORTI A, MAZZA E, ARCIERI K, GIACOMONI A, MINOLA E, IDÉO G, FORTI D.
“Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?”
Transplant Proc. 1997 Feb-Mar;29(1-2):492-4.

BELLATI G, COLLOREDO G, ROFFI L, D'AQUINO M, BONINO F, IDÉO G.
“Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G.”
J Hepatol. 1997 Feb;26(2):449-50.

SCHALM SW, BROUWER JT, CHEMELLO L, ALBERTI A, BELLOBUONO A, IDÉO G, SCHWARTZ R, WEILAND O.
“Interferon-ribavirin combination therapy for chronic hepatitis C.”
Dig Dis Sci. 1996 Dec;41(12 Suppl):131S-134S.

ZAVAGLIA C, MONDAZZI L, FESCE E, IAMONI G, LANZANI F, IDÉO G.
“Severe acute hepatitis associated with morphazinamide therapy.”
J Hepatol. 1996 Dec;25(6):1001.

COLLOREDO G, BELLATI G, LEANDRO G, COLOMBATTO P, RHO A, BISSOLI F, BRUNETTO MR, ANGELI G, IDÉO G, BONINO F.
“Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values.”
J Hepatol. 1996 Nov;25(5):644-8.

BELLI LS, IDÉO G, SILINI E.
“Hepatitis G virus and post-transplantation hepatitis.”
N Engl J Med. 1996 Oct 31;335(18):1394-5.

MAGGI G, BOTTELLI R, GOLA D, PERRICONE G, POSCA M, ZAVAGLIA C, IDÉO G.
“Serum cholesterol and chronic hepatitis C.”
Ital J Gastroenterol. 1996 Oct-Nov;28(8):436-40.

ANDREONE P, CURSARO C, GRAMENZI A, ZAVAGLIZ C, REZAKOVIC I, ALTOMARE E, SEVERINI R, FRANZONE JS, ALBANO O, IDÉO G, BERNARDI M, GASBARRINI G.
“A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients witH hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.”
Hepatology. 1996 Oct;24(4):774-7.

ZAVAGLIA C, BOTTELLI R, SMEDILE A, IAMONI G, MONDAZZI L, AIROLDI A, LANZANI F, IDÉO G.
“A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D.”
J Clin Gastroenterol. 1996 Sep;23(2):162-3.

FAGIUOLI S, LEANDRO G, BELLATI G, GASBARRINI A, RAPACCINI GL, POMPILI M, RENDINA M, DE NOTARIIS S, FRANCAVILLA A, GASBARRINI G, IDÉO G, NACCARATO R.
“Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group.”
Ital J Gastroenterol. 1996 Jul-Aug;28(6):343-50.

ZAVAGLIA C, BOTTELLI R, BELLATI G, ASTI L, MONDAZZI L, IAMONI G, ZANETTI A, TANZI E, FESCE E, GELOSA F, MAGGI G, IDÉO G.
“Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.”
Ital J Gastroenterol. 1996 Jul-Aug;28(6):324-31.

SILINI E, BOTTELLI R, ASTI M, BRUNO S, CANDUSSO ME, BRAMBILLA S, BONO F, IAMONI G, TINELLI C, MONDELLI MU, IDÉO G.
“Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.”
Gastroenterology. 1996 Jul;111(1):199-205.

ZAVAGLIA C, BORTOLON C, FERRIOLI G, RHO A, MONDAZZI L, BOTTELLI R, GHESSI A, GELOSA F, IAMONI G, IDÉO G.
“HLA typing in chronic type B, D and C hepatitis.”
J Hepatol. 1996 Jun;24(6):658-65.

ZAVAGLIA C, BARBERIS M, GELOSA F, CIMINO G, MINOLA E, MONDAZZI L, BOTTELLI R, IDÉO G.
“Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases.”
Ital J Gastroenterol. 1996 Apr;28(3):152-9.

COLELLA G, RONDINARA GF, DE CARLIS L, SANSALONE CV, SLIM AO, ASENI P, ROSSETTI O, DE GASPERI A, MINOLA E, BOTTELLI R, BELLI LS, IDÉO G, FORTI D.
“Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival.”
Transpl Int. 1996;9 Suppl 1:S109-11.

MENOTTI A, SECCARECCIA F, LANTI M, FARCHI G, CONTI S, DIMA F, SCANGA M, MARENCO G, FALCHERO M, IDÉO G, ET AL.
“Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy.”
G Ital Cardiol. 1995 Dec;25(12):1539-72.

IDÉO G, BELLOBUONO A, MONDAZZI L, TEMPINI S, BELLATI G, IDÉO GM, SILINI E.
“Alpha interferon treatment in chronic hepatitis C.”
Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S167-73.

BELLOBUONO A, BELLATI G, MONDAZZI L, TEMPINI S, FESCE E, IDÉO GM, IDÉO G.
“[Treatment with interferon-alpha in chronic hepatitis C. A gradual discontinuation of the drug till
the end of the therapy can reduce disease recurrence].”
Minerva Gastroenterol Dietol. 1995 Mar;41(1):107-11.

MAROTTA F, CHUI DH, SAFRAN P, REZAKOVIC I, ZHONG GG, IDÉO G.
“Shark fin enriched diet prevents mucosal lipid abnormalities in experimental acute colitis.”
Digestion. 1995;56(1):46-51.